Galectin-3 released in response to traumatic brain injury acts as an alarmin orchestrating brain immune response and promoting neurodegeneration

Traumatic brain injury (TBI) is currently a major cause of morbidity and poor quality of life in Western society, with an estimate of 2.5 million people affected per year in Europe, indicating the need for advances in TBI treatment. Within the first 24 h after TBI, several inflammatory response fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Yip, Ping Kei, Carrillo-Jimenez, Alejandro, King, Paul, Vilalta, Anna, Nomura, Koji, Chau, Chi Cheng, Egerton, Alexander Michael Scott, Liu, Zhuo-Hao, Shetty, Ashray Jayaram, Tremoleda, Jordi L., Davies, Meirion, Deierborg, Tomas, Priestley, John V., Brown, Guy Charles, Michael-Titus, Adina Teodora, Venero, Jose Luis, Burguillos, Miguel Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269662/
https://www.ncbi.nlm.nih.gov/pubmed/28128358
http://dx.doi.org/10.1038/srep41689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269662/
https://www.ncbi.nlm.nih.gov/pubmed/28128358
http://dx.doi.org/10.1038/srep41689

Ejemplares similares